Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
PMID: 3583493 Bes F, Hofman W, Schuur J, Van Boxtel C
The Bottom Line The shifting regulatory picture is potentially good news for patients who benefit from peptide therapies, depending on PCACs July decision
The BPC-157 peptide is documented in peer-reviewed literature as acting through at least two distinct, non-redundant molecular pathways simultaneously which may explain its unusually broad tissue-repair activity profile
Great company to do business with
US$ 26.47
US$ 25.63
US$ 21.98
US$ 23.09
US$ 24.90
US$ 23.42
US$ 29.29
US$ 20.11
